secwatch / observer
8-K filed April 16, 2026, 7:59 PM ET ticker ALT CIK 0001326190
other confidence high sentiment neutral materiality 0.50

Altimmune shareholders approve doubling authorized shares to 400M, re-elect all directors

Altimmune, Inc.

item 5.03item 5.07item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001326190-26-000027
form_type
8-K
ticker
ALT
cik
0001326190
company_name
Altimmune, Inc.
filed_at
2026-04-16T23:59:59+00:00
discovered_at
2026-05-14T18:02:32.135181+00:00
generated_at
2026-05-15T05:43:32.973710+00:00
sec_items
["5.03", "5.07", "9.01"]
event_type
other
sentiment
neutral
materiality_score
0.5
calibrated_materiality_score
0.5
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001326190-26-000027
json_url
https://secwatch.observer/filing/0001326190-26-000027.json
markdown_url
https://secwatch.observer/filing/0001326190-26-000027.md
text_url
https://secwatch.observer/filing/0001326190-26-000027.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1326190/000132619026000027/0001326190-26-000027-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1326190/000132619026000027/alt-20260416x8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

80318b686fd9419f513be37d0bbffcdd5d269e3d

Altimmune, Inc.: Amended certificate of incorporation to increase authorized common stock from 200,000,000 to 400,000,000 shares (effective 2026-04-16).

On April 16, 2026, Altimmune, Inc. (the “Company”) amended its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) by filing a Certificate of Amendment with the Secretary of State of Delaware. The Certificate of Amendment reflected an amendment to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

Comparable filings

BAX

Baxter shareholders approve charter amendment and incentive plan; board adopts new executive severance plan

BAXTER INTERNATIONAL INC May 8, 2026, 7:59 PM ET other Items 5.02, 5.07, 5.03, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other similar materiality

This filing

On April 16, 2026, Altimmune, Inc. (the “Company”) amended its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) by filing a Certificate of Amendment with the Secretary of State of Delaware. The Certificate of Amendment reflected an amendment to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000

Comparable filing

the Board approved a corresponding amendment and restatement of the Company’s Amended and Restated Bylaws (the “Amended Bylaws”) reflecting that the number of directors on the Board shall not be less than seven nor more than twelve

Filing page SEC filing

KGS

Kodiak shareholders approve board declassification and supermajority removal

Kodiak Gas Services, Inc. May 7, 2026, 7:59 PM ET other Items 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other similar materiality

This filing

On April 16, 2026, Altimmune, Inc. (the “Company”) amended its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) by filing a Certificate of Amendment with the Secretary of State of Delaware. The Certificate of Amendment reflected an amendment to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000

Comparable filing

At the 2026 Annual Meeting of Shareholders (the “Annual Meeting”) of Kodiak Gas Services, Inc. (the “Company”) held on May 7, 2026, the Company’s shareholders approved certain amendments (the “Charter Amendments”) to the Company’s Amended and Restated Certificate of Incorporation (the “Charter”) to (i) phase in declassification of the Board of Directors (the “Board”) and (ii) eliminate certain supermajority voting requirements and other obsolete provisions.

Filing page SEC filing

PLUN

Plutonian Acquisition Corp II closes $100M IPO of 10M units at $10/unit

Plutonian Acquisition Corp. II April 30, 2026, 7:59 PM ET other Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 5.03, 9.01 same event type: other similar materiality

This filing

On April 16, 2026, Altimmune, Inc. (the “Company”) amended its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) by filing a Certificate of Amendment with the Secretary of State of Delaware. The Certificate of Amendment reflected an amendment to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000

Comparable filing

On April 27, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Filing page SEC filing

RNST

Renasant Corp. shareholders elect all 17 directors, approve executive compensation and auditor at 2026 annual meeting

RENASANT CORP May 1, 2026, 7:59 PM ET other Items 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other

This filing

On April 16, 2026, Altimmune, Inc. (the “Company”) amended its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) by filing a Certificate of Amendment with the Secretary of State of Delaware. The Certificate of Amendment reflected an amendment to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000

Comparable filing

On April 28, 2026, the Board of Directors (the “Board”) of Renasant Corporation (“Renasant”) approved and adopted Amended and Restated Bylaws of Renasant Corporation (the “Bylaws”), which became effective immediately.

Filing page SEC filing

RVTY

Revvity shareholders approve bylaw amendment allowing 25% owners to call special meetings; all director nominees elected

REVVITY, INC. May 1, 2026, 7:59 PM ET other Items 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other

This filing

On April 16, 2026, Altimmune, Inc. (the “Company”) amended its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) by filing a Certificate of Amendment with the Secretary of State of Delaware. The Certificate of Amendment reflected an amendment to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000

Comparable filing

At the annual meeting of shareholders of Revvity, Inc. (the “Company”) held on April 28, 2026, the shareholders voted on and approved a proposal to amend the Company’s Amended and Restated By-laws (prior to such amendment and restatement, the “Prior By-laws”) to allow shareholders owning 25% of the Company’s stock to call a special meeting of shareholders (as amended and restated, the “Amended and Restated By-laws”) effective as of April 28, 2026.

Filing page SEC filing

BMI

Badger Meter annual meeting: all directors elected, bylaw amendments approved

BADGER METER INC April 28, 2026, 7:59 PM ET other Items 5.03, 5.07, 8.01, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other

This filing

On April 16, 2026, Altimmune, Inc. (the “Company”) amended its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) by filing a Certificate of Amendment with the Secretary of State of Delaware. The Certificate of Amendment reflected an amendment to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000

Comparable filing

On April 24, 2026, the Board of Directors (the Board) of Badger Meter, Inc. (the Company) approved an amendment and restatement of the Company’s Restated By-laws (the By-laws), including to: • Clarify the notice and adjournment requirements applicable to shareholder meetings conducted by means of remote communication. • Provide that, in the case of a meeting held solely by means of remote communication, the shareholder list must be open to the examination of any shareholder during the entire meeting on a reasonably accessible electronic network. • Expand the disclosures required from shareholders to propose business or nominate directors for election at the Company’s annual meeting of shareholders. • Update the advance notice deadlines for shareholder proposals and nominations to not less than 90 days nor more than 120 days before the second Saturday in the month of April, or, if the annual meeting is advanced by more than 30 days or delayed by more than 60 days from the second Saturda

Filing page SEC filing

SCHW

Charles Schwab files Certificate of Elimination for Series I Preferred Stock

SCHWAB CHARLES CORP June 1, 2026, 5:00 PM ET other Items 5.03, 9.01

same fact type: governance_change same SEC item: 5.03, 9.01 same event type: other

This filing

On April 16, 2026, Altimmune, Inc. (the “Company”) amended its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) by filing a Certificate of Amendment with the Secretary of State of Delaware. The Certificate of Amendment reflected an amendment to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000

Comparable filing

On June 1, 2026, The Charles Schwab Corporation (the “Company”) filed a Certificate of Elimination with the Secretary of State of the State of Delaware with respect to the Company’s 4.000% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series I (“Series I Preferred Stock”), which, effective upon filing, eliminated from the Company’s Fifth Restated Certificate of Incorporation, as amended, all matters set forth in the Certificate of Designations for the Series I Preferred Stock.

Filing page SEC filing

SCI

SCI shareholders approve board governance changes: director minimum cut to 3, board can fill vacancies

SERVICE CORP INTERNATIONAL May 8, 2026, 7:59 PM ET other Items 5.03, 9.01

same fact type: governance_change same SEC item: 5.03, 9.01 same event type: other

This filing

On April 16, 2026, Altimmune, Inc. (the “Company”) amended its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) by filing a Certificate of Amendment with the Secretary of State of Delaware. The Certificate of Amendment reflected an amendment to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000

Comparable filing

The amendments to the Articles of Incorporation, which became effective on May 7, 2026, and the amendments to the Bylaws, which became effective on May 6, 2026 , include (i) changes permitting the Board to increase the number of directors and fill newly created vacancies, thereby eliminating restrictions requiring that newly created directorships be filled only by shareholders at an annual or special meeting, and (ii) changes reducing the minimum number of directors constituting the Board from nine to three directors (with the maximum remaining at fifteen directors).

Filing page SEC filing

Source: SEC EDGAR
accession 0001326190-26-000027
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.